Global Pharmaceuticals & Biotech Upcoming Dividends

Human Metabolome Technologies

Market Cap: JP¥4.3b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Chugai Pharmaceutical

Market Cap: JP¥10.1t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Fuso Pharmaceutical IndustriesLtd

Market Cap: JP¥18.7b

Manufactures and sells pharmaceuticals and medical equipment in Japan.

JCR Pharmaceuticals

Market Cap: JP¥76.2b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Bliss GVS Pharma

Market Cap: ₹17.8b

Engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally.

Dong-A Socio Holdings

Market Cap: ₩709.9b

Engages in the pharmaceutical business in South Korea.

Towa Pharmaceutical

Market Cap: JP¥146.5b

Manufactures and sale ethical drugs in Japan.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.9b

Engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally.

Procter & Gamble Health

Market Cap: ₹104.4b

Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.

Shanghai New World

Market Cap: CN¥4.8b

Owns and operates department stores in China.

Alembic Pharmaceuticals

Market Cap: ₹188.1b

An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

Seikagaku

Market Cap: JP¥35.1b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

Kopran

Market Cap: ₹7.6b

An integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally.

KYORIN Pharmaceutical

Market Cap: JP¥89.4b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

Eli Lilly

Market Cap: US$592.9b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Sunmax Biotechnology

Market Cap: NT$22.7b

A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.

SMS Pharmaceuticals

Market Cap: ₹20.8b

Manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally.

Astena Holdings

Market Cap: JP¥20.5b

Manufactures and sells medicine-related products in Japan.

TTK Healthcare

Market Cap: ₹15.9b

Engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India.

Domesco Medical Import - Export

Market Cap: ₫2.2t

Engages in the research and development, manufacturing, marketing, and trading of pharmaceutical products, herbal-origin medicines, functional foods, purified drinking water, and herbal-based beverages in Vietnam.

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Market Cap: ₺59.9b

A pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.

Marksans Pharma

Market Cap: ₹80.9b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

Cenra

Market Cap: NT$5.1b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Alivus Life Sciences

Market Cap: ₹115.8b

Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.

Haw Par

Market Cap: S$3.1b

Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.

Themis Medicare

Market Cap: ₹9.3b

Manufactures and sells pharmaceutical products in India and internationally.

Windlas Biotech

Market Cap: ₹21.9b

A contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India.

Lotus Pharmaceutical

Market Cap: NT$54.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Gland Pharma

Market Cap: ₹325.5b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.